[1]
|
Sharma, S.K., Kumar, S., Saha, P.K., George, N., Arora, S.K., Gupta, D., Singh, U., Hanif, M. and Vashisht, R.P. (2011) Prevalence of Multidrug-Resistant Tuberculosis among Category II Pulmonary Tuberculosis Patients. Indian Journal of Medical Research, 133, 312-315.
|
[2]
|
World Health Organization (2008) Guidelines for the Programmatic Management of Drug- Resistant Tuberculosis Emergency update 2008. (WHO/HTM/TB/2008.402)
|
[3]
|
Nathanson, E., Weezenbeek, C.L., Rich, M.L., Gupta, R., Bayona, J., Blöndal, K., Caminero, J.A., Cegielski, J.P., Danilovits, M., Espinal, M.A., Hollo, V., Jaramillo, E., Leimane, V., Mitnick, C.D., Mukherjee, J.S., Nunn, P., Pasechnikov, A., Tupasi, T., Wells, C. and Raviglione, M.C. (2006) Multidrug-Resistant Tuberculosis Management in Resource-Limited Settings. Emerging Infectious Diseases, 12, 1389-1397. www.cdc.gov/eid
http://dx.doi.org/10.3201/eid1209.051618
|
[4]
|
Ormerod, L.P. (2005) Multidrug-Resistant Tuberculosis (MDR-TB): Epidemiology, Prevention and Treatment. British Medical Bulletin, 73-74, 17-24.
|
[5]
|
Burgos, M., Gonzalez, L.C., Paz, E.A., Gournis, E., Kawamura, L.M., Schecter, G., Hopewell, P.C. and Daley, C.L. (2005) Treatment of Multidrug-Resistant Tuberculosis in San Francisco: An Outpatient-Based Approach. Clinical Infectious Diseases, 40, 968-975.
http://dx.doi.org/10.1086/428582
|
[6]
|
Jacobson, K.R., Tierney, D.B., Jeon, C.Y., Mitnick, C.D. and Murray, M.B. (2010) Treatment Outcomes among Patients with Extensively Drug-Resistant Tuberculosis: Systematic Review and Meta-Analysis. Clinical Infectious Diseases, 51, 6-14. http://dx.doi.org/10.1086/653115
|
[7]
|
Sudan National Tuberculosis Control Programme. Progress Report January-December. Federal Ministry of Health. General Directorate of Primary Health Care, 2012.
|
[8]
|
Sharaf Eldin, G.S., Fadl-Elmula, I., Ali, M.S., Ali, A.B., Salih, A.G.A., Mallard, K., Bottomley, C. and McNerney, R. (2011) Tuberculosis in Sudan: A Study of Mycobacterium tuberculosis Strain Genotype and Susceptibility to Anti-Tuberculosis Drugs. BMC Infectious Diseases, 11, 219. http://dx.doi.org/10.1186/1471-2334-11-219
|
[9]
|
Hassan, S.O., Musa, M.T., Elsheikh, H.M., Eleragi, A.M.S. and Saeed, N.S. (2012) Drug Resistance in Mycobacterium tuberculosis Isolates from Northeastern Sudan. British Journal of Medicine & Medical Research, 2, 424-433. http://dx.doi.org/10.9734/BJMMR/2012/1404
|
[10]
|
World Health Organization. Policy Guidance on Drug-Susceptibility Testing (DST) of Second-Line Anti Tuberculosis Drugs. Geneva WHO/HTM/TB/2008b.392.
|
[11]
|
World Health Organization. Assessing Tuberculosis Prevalence through Population-Based Surveys. 2007aISBN 978 92 9061 314 5 (NLM Classification: WF 300).
|
[12]
|
Saeed, W., Naseem, A. and Ahmed, J. (2009) Retrospective Audit of Patients Treated for MDR-TB in Retreatment Category. Journal Pakistan Medical Association, 21, S70-S74.
|
[13]
|
Dalton, T., Cegielski, P., Akksilp, S., Asencios, L., Caoili, J.C., Cho, S., Erokhin, V.V., Ershova, J., Gler, M.T., Kazennyy, B.Y., Kim, H.J., Kliiman, K., Kurbatova, E., Kvasnovsky, C., Leimane, V., van der Walt, M., Via, L.E., Volchenkov, G.V., Yagui, M.A. and Kang, H., the Global PETTS Investigators (2012) Prevalence of and Risk Factors for Resistance to Second- Line Drugs in People with Multidrug-Resistant Tuberculosis in Eight Countries: A Prospective Cohort Study. The Lancet, 380, 1406-1417. www.thelancet.com
|
[14]
|
Frieden, T. (2004) Toman’s Tuberculosis Case Detection, Treatment, and Monitoring— Questions and Answers. WHO/HTM/TB, 334, 2nd Edition. (NLM Classification: WF 360)
|
[15]
|
Mdivani, N., Zangaladze, E., Volkova, N., Kourbatova, E., Jibuti, T., Shubladze, N., Kutateladze, T., Khechinashvili, G., del Rio, C., Salakaia, A. and Blumberg, H.M. (2008) High Prevalence of Multidrug-Resistant Tuberculosis in Georgia. International Journal of Infectious Diseases, 12, 635-644. http://intl.elsevierhealth.com/journals/ijid
http://dx.doi.org/10.1016/j.ijid.2008.03.012
|
[16]
|
Umubyeyi, A., Rigouts, L., Shamputa, I.C., Dediste, A., Struelens, M. and Portaels, F. (2008) Low Levels of Second-Line Drug Resistance among Multidrug-Resistant Mycobacterium tuberculosis Isolates from Rwanda. International Journal of Infectious Diseases, 12, 152-156.
http://intl.elsevierhealth.com/journals/ijid
http://dx.doi.org/10.1016/j.ijid.2007.05.003
|
[17]
|
Magdorf, K., Ertel, M., Grassot, A. and Wahn, U. (1996) Tuberculin Conversion and Abnormal Chest Radiograph in an Infant. European Respiratory Journal, 9, 1763-1765.
http://dx.doi.org/10.1183/09031936.96.09081763
|
[18]
|
Girón, R.M., Domingo, D., Buendía, B., Antón, E., Ruiz-Velasco, L.M. and Ancochea, J. (2005) Nontuberculous mycobacteria in Patients with Cystic Fibrosis. Archivos de Bronconeumología, 41, 560-565.
|
[19]
|
Nasiri, M.J., Rezaei, F., Zamani, S., Darban-Sarokhalil, D., Fooladi, A.A.I., Shojaei, H. and Feizabadi, M.M. (2014) Drug Resistance Pattern of Mycobacterium tuberculosis Isolates from Patients of Five Provinces of Iran Asian Pacific. Journal of Tropical Medicine, 193-196.
www.elsevier.com/locate/apjtm
|
[20]
|
Shamaei, M., Marjani, M., Chitsaz, E., Kazempour, M., Esmaeili, M., Farnia, P., Tabarsi, P., Amiri, M.V., Mirsaeidi, M., Mansouri, D., Masjedi, M.R. and Velayati, A.A. (2009) First- Line Anti-Tuberculosis Drug Resistance Patterns and Trends at the National TB Referral Center in Iran—Eight Years of Surveillance. International Journal of Infectious Diseases, 13, e236-e240. http://intl.elsevierhealth.com/journals/ijid
http://dx.doi.org/10.1016/j.ijid.2008.11.027
|
[21]
|
Abate, D., Taye, B., Abseno, M. and Biadgilign, S. (2012) Epidemiology of Anti-Tuberculosis Drug Resistance Patterns and Trends in Tuberculosis Referral Hospital in Addis Ababa, Ethiopia. BMC Research Notes, 5, 462. http://www.biomedcentral.com/1756-0500/5/462
http://dx.doi.org/10.1186/1756-0500-5-462
|
[22]
|
Cegielski, J.P. (2010) Extensively Drug-Resistant Tuberculosis: “There Must Be Some Kind of Way Out of Here”. Clinical Infectious Diseases, 50, S195-S200.
http://dx.doi.org/10.1086/651491
|
[23]
|
Daniel, O., Osman, E., Oladimeji, O. and Dairo, O.O. (2013) Pre-Extensive Drug Resistant Tuberculosis (Pre-XDR-TB) among MDR-TB Patients in Nigeria. Global Advanced Research Journal of Microbiology, 2, 22-25. http://garj.org/garjm/index.htm
|
[24]
|
Ndung’u, P.W., Kariuki, S., Ng’ang’a, Z. and Revathi, G. (2012) Resistance Patterns of Mycobacterium tuberculosis Isolates from Pulmonary Tuberculosis Patients in Nairobi. Journal of Infection in Developing Countries, 6, 33-39.
|
[25]
|
Mani, C., Selvakumar, N., Narayanan, S. and Narayanan, P.R. (2001) Mutations in the rpoBGene of Multidrug-Resistant Mycobacterium tuberculosis Clinical Isolates from India. Journal of Clinical Microbiology, 39, 2987-2990.
http://dx.doi.org/10.1128/JCM.39.8.2987-2990.2001
|
[26]
|
Yam, W.C., Tam, C.M., Leung, C.C., Tong, H.L., Chan, K.H., Leung, E.T.Y., Wong, K.C., Yew, W.W., Seto, W.H., Yuen, K.Y. and Ho, P.L. (2004) Direct Detection of Rifampin- Resistant Mycobacterium tuberculosis in Respiratory Specimens by PCR-DNA Sequencing Journal of Clinical Microbiology, 42, 4438-4443.
http://dx.doi.org/10.1128/JCM.42.10.4438-4443.2004
|